ANNX
Annexon Inc
NASDAQ: ANNX · HEALTHCARE · BIOTECHNOLOGY
$5.87
-0.34% today
Updated 2026-04-30
Market cap
$943.59M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $7
Volume
2.7M
Annexon Inc (ANNX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+1.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+15.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+10.5%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+17.8%
2026-03-09
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-09 | $-0.28 | +12.5% | $5.16 | $6.08 | +17.8% |
| 2025-11-10 | $-0.37 | -3.2% | $2.88 | $2.97 | +3.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.32 | $-0.28 | +12.5% | — | — |
| 2025-09-30 | $-0.36 | $-0.37 | -3.2% | — | — |
| 2025-06-30 | $-0.36 | $-0.34 | +5.6% | — | — |
| 2025-03-31 | $-0.34 | $-0.37 | -8.8% | — | — |
| 2024-12-31 | $-0.29 | $-0.33 | -12.5% | $3.40M | -30.0% |
| 2024-09-30 | $-0.26 | $-0.25 | +3.8% | — | — |
| 2024-06-30 | $-0.23 | $-0.23 | +0.0% | — | — |
| 2024-03-31 | $-0.34 | $-0.21 | +38.2% | — | — |
| 2023-12-31 | $-0.44 | $-0.36 | +18.2% | $4.87M | — |
| 2023-09-30 | $-0.50 | $-0.43 | +14.0% | — | — |
| 2023-06-30 | $-0.54 | $-0.47 | +13.0% | — | — |
| 2023-03-31 | $-0.52 | $-0.52 | +0.0% | — | — |
Frequently asked questions
Has Annexon Inc beaten earnings estimates?
Annexon Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +1.5% over the last 4 quarters.
How does ANNX stock react to earnings?
ANNX stock has moved an average of +10.5% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.